The Federal Register http://thefederalregister.com/b.p/agency/Drug_Enforcement_Administration/2006-12-07/ Daily Publications of Meetings and Rules Changes for the Federal Government Thu, Dec 4 2008 11:00:00 GMT Thu, Dec 4 2008 11:00:00 GMT info@thefederalregister.com <![CDATA[ Importer of Controlled Substances; Notice of Registration ]]> http://thefederalregister.com/d.p/2006-12-07-E6-20747

By Notice dated August 15, 2006 and published in the Federal Register on August 22, 2006, (71 FR 48945), Applied Science Labs, Division of Alltech Associates Inc., 2701 Carolean Industrial Drive, State College, Pennsylvania 16801, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as an importer of the basic classes of controlled substances listed in schedule I and ]]> http://thefederalregister.com/d.p/2006-12-07-E6-20747 Thu, Dec 7 2006 11:00:00 GMT <![CDATA[ Manufacturer of Controlled Substances; Notice of Application]]> http://thefederalregister.com/d.p/2006-12-07-E6-20694

Pursuant to Sec. 1301.33(a) of Title 21 of the Code of Federal Regulations (CFR), this is notice that on August 24, 2006, Cayman Chemical Company, 1180 East Ellsworth Road, Ann Arbor, Michigan 48108, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in schedule I:
Drug Schedule Marihuana (7360)............................. I

Tetrahydrocannabinols (7370)................. I

The company plans to manufacture small quantities of marihuana derivatives for research purposes. In reference to drug code 7360 (Marihuana), the company plans to bulk manufacture cannabidiol. In reference to drug code 7370 (Tetrahydrocannabinols), the company will manufacture a synthetic THC. No other activity for this drug code is authorized for registration.

Any other such applicant and any person who is presently registered with DEA to manufacture ]]> http://thefederalregister.com/d.p/2006-12-07-E6-20694 Thu, Dec 7 2006 11:00:00 GMT <![CDATA[ Manufacturer of Controlled Substances; Notice of Registration]]> http://thefederalregister.com/d.p/2006-12-07-E6-20690

By Notice dated June 9, 2006, and published in the Federal Register on June 19, 2006, (71 FR 3531035311), Cedarburg Pharmaceuticals, Inc., 870 Badger Circle, Grafton, Wisconsin 53024, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in schedules I and II:
Drug Schedule Tetrahydrocannabinols (7370)............... I
Dihydromorphine (9145)..................... I
Oxycodone (9143)........................... II
Hydrocodone (9193)......................... II

Hydromorphone (9150)....................... II

The firm plans to manufacture the listed controlled substances in bulk for distribution to its customers. By letter dated September 5, 2006, the company has withdrawn their request for the addition of Methylphenidate (1724), to their application for registration.

No comments or objections have been received. DEA has considered ]]> http://thefederalregister.com/d.p/2006-12-07-E6-20690 Thu, Dec 7 2006 11:00:00 GMT <![CDATA[ Manufacturer of Controlled Substances; Notice of Registration]]> http://thefederalregister.com/d.p/2006-12-07-E6-20693

By Notice dated July 19, 2006, and published in the Federal Register on July 26, 2006, (71 FR 42417), Lin Zhi International, Inc., 687 North Pastoria Avenue, Sunnyvale, California 94085, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in schedule I and II:
Drug Schedule Tetrahydrocannabinols (7370)............... I
3,4Methylenedioxymethamphetamine (7405).. I
Cocaine (9041)............................. II
Oxycodone (9143)........................... II
Hydrocodone (9193)......................... II
Methadone (9250)........................... II
Dextropropoxyphene, bulk (9273)............ II

Morphine (9300)............................ II

The company plans to manufacture the listed controlled substances as bulk reagents for use in drug abuse testing.

No comments or objections have been received. DEA has considered the fa ]]> http://thefederalregister.com/d.p/2006-12-07-E6-20693 Thu, Dec 7 2006 11:00:00 GMT <![CDATA[ Importer of Controlled Substances; Notice of Registration ]]> http://thefederalregister.com/d.p/2006-12-07-E6-20745

By Notice dated July 10, 2006 and published in the Federal Register on July 24, 2006, (71 FR 4183741838), Lipomed Inc., One Broadway, Cambridge, Massachusetts 02142, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as an importer of the basic classes of controlled substances listed in schedule I and II: Drug Schedule Cathinone (1235)........................... I
Methcathinone (1237)....................... I
NEthylamphetamine (1475).................. I
Methaqualone (2565)........................ I
Gamma hydroxybutyric acid (2010)........... I
Lysergic acid diethylamide (7315), 2,5 I
Dimethoxy4(n)propylthiophenethylamine
(7438).
Marihuana (7360)........................... I
Tetrahydrocannabinols (7370)............... I
Mescaline (7381)........................... I
3,4,5Trimethoxyamphetamine (7390)......... I
4Bromo2,5dimethoxyamphetamine (7391).... I
4Bromo2,5dimethoxyphenethylamine (7392). I
4M ]]> http://thefederalregister.com/d.p/2006-12-07-E6-20745 Thu, Dec 7 2006 11:00:00 GMT <![CDATA[ Manufacturer of Controlled Substances; Notice of Registration]]> http://thefederalregister.com/d.p/2006-12-07-E6-20689

By Notice dated July 25, 2006, and published in the Federal Register on July 31, 2006, (71 FR 43211), MGI Pharma, 6611 Tributary Street, Baltimore, Maryland 21224, made application to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of Cocaine (9041),
[[Page 70987]]
a basic class of controlled substance listed in schedule II.

The company plans to manufacture a cocaine derivative to be used in domestic and foreign clinical research studies.

No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of MGI Pharma to manufacture the listed basic class of controlled substance is consistent with the public interest at this time. DEA has investigated MGI Pharma to ensure that the company's registration is consistent with the public interest. The investigation has included inspection and testing of the company's physical security systems, verification of the company's compliance with S ]]> http://thefederalregister.com/d.p/2006-12-07-E6-20689 Thu, Dec 7 2006 11:00:00 GMT <![CDATA[ Manufacturer of Controlled Substances; Notice of Registration]]> http://thefederalregister.com/d.p/2006-12-07-E6-20744

By Notice dated July 26, 2006, and published in the Federal Register on August 2, 2006, (71 FR 43814), Orasure Technologies, Inc., Lehigh University, Seeley G. MuddBuilding 6, Bethlehem, Pennsylvania 18015, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in schedules I and II: Drug Schedule Lysergic acid diethylamide (LSD) (7315).... I
4Methoxyamphetamine (7411)................ I
Normorphine (9313)......................... I
Tetrahydrocannabinols (THC) (7370)......... I
Alphamethadol (9605)....................... I
Amphetamine (1100)......................... II
Methamphetamine (1105)..................... II
Cocaine (9041)............................. II
Hydromorphone (9150)....................... II
Benzoylecgonine (9180)..................... II
Hydrocodone (9193)......................... II
Morphine (9300)................. ]]> http://thefederalregister.com/d.p/2006-12-07-E6-20744 Thu, Dec 7 2006 11:00:00 GMT <![CDATA[ Manufacturer of Controlled Substances; Notice of Application]]> http://thefederalregister.com/d.p/2006-12-07-E6-20698

Pursuant to Sec. 1301.33(a) of Title 21 of the Code of Federal Regulations (CFR), this is notice that on September 20, 2006, Organix Inc., 240 Salem Street, Woburn, Massachusetts 01801, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of Cocaine (9041), a basic class of controlled substance listed in schedule II.

The company plans to manufacture a chemical that is a derivative of cocaine that will be sold to their customer for research purposes.

Any other such applicant and any person who is presently registered with DEA to manufacture such a substance may file comments or objections to the issuance of the proposed registration pursuant to 21 CFR 1301.33(a).

Any such written comments or objections being sent via regular mail should be addressed, in quintuplicate, to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, Washington, DC 20537, Attention: DEA Federal Register ]]> http://thefederalregister.com/d.p/2006-12-07-E6-20698 Thu, Dec 7 2006 11:00:00 GMT <![CDATA[ Importer of Controlled Substances; Notice of Registration ]]> http://thefederalregister.com/d.p/2006-12-07-E6-20739

By Notice dated August 7, 2006 and published in the Federal Register on August 15, 2006, (71 FR 46922), Penick Corporation, 33 Industrial Park Road, Pennsville, New Jersey 08070, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as an importer of the basic classes of controlled substances listed in schedule II:
Drug Schedule Coca Leaves (9040)......................... II
Raw Opium (9600)........................... II
Poppy Straw (9650)......................... II

Concentrate of Poppy Straw (9670).......... II

The company plans to import the listed controlled substances to manufacture bulk controlled substance intermediates for sale to its customers.

No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and 952(a) and determined that the registration of Penick Corporation to import the basic classes of controlled substances is consistent with the public ]]> http://thefederalregister.com/d.p/2006-12-07-E6-20739 Thu, Dec 7 2006 11:00:00 GMT <![CDATA[ Manufacturer of Controlled Substances; Notice of Registration]]> http://thefederalregister.com/d.p/2006-12-07-E6-20688

By Notice dated July 10, 2006, and published in the Federal Register on July 26, 2006, (71 FR 42418), Polaroid Corporation, 1265 Main Street, Building W6, Waltham, Massachusetts 02454, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of 2,5Dimethoxyamphetamine (7396), a basic class of controlled substance listed in schedule I.

The company plans to manufacture the listed controlled substance in bulk for conversion into a noncontrolled substance.

No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Polaroid Corporation to manufacture the listed basic class of controlled substance is consistent with the public interest at this time. DEA has investigated Polaroid Corporation to ensure that the company's registration is consistent with the public interest. The investigation has included inspection and testing of the company's physical security ]]> http://thefederalregister.com/d.p/2006-12-07-E6-20688 Thu, Dec 7 2006 11:00:00 GMT <![CDATA[ Importer of Controlled Substances; Notice of Registration ]]> http://thefederalregister.com/d.p/2006-12-07-E6-20746

By Notice dated August 15, 2006 and published in the Federal Register on August 22, 2006 (71 FR 48947), Research Triangle Institute, Kenneth H. Davis Jr., Hermann Building East Institute Drive, P.O. Box 12194, Research Triangle Park, North Carolina 27709, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as an importer of Cocaine (9041), a basic class of controlled substance listed in schedule II.

The company plans to import small quantities of the listed controlled substance for the National Institute on Drug Abuse and other clients.

No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and 952(a) and determined that the registration of Research Triangle Institute to import the basic class of controlled substance is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971, at this time. DEA has investigated ]]> http://thefederalregister.com/d.p/2006-12-07-E6-20746 Thu, Dec 7 2006 11:00:00 GMT <![CDATA[ Manufacturer of Controlled Substances; Notice of Application]]> http://thefederalregister.com/d.p/2006-12-07-E6-20691

Pursuant to Sec. 1301.33(a) of Title 21 of the Code of Federal Regulations (CFR), this is notice that on September 21, 2006, Rhodes Technologies, 498 Washington Street, Coventry, Rhode Island 02816, made application by letter to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of Oxymorphone (9652), a basic class of controlled substance listed in schedule II.

The company plans to manufacture the listed controlled substance in bulk for conversion and sale to dosage form manufacturers.

Any other such applicant and any person who is presently registered with DEA to manufacture such a substance may file comments or objections to the issuance of the proposed registration pursuant to 21 CFR 1301.33(a).

Any such written comments or objections being sent via regular mail should be addressed, in quintuplicate, to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, Washington, DC 20537, Attention: DEA Federal Re ]]> http://thefederalregister.com/d.p/2006-12-07-E6-20691 Thu, Dec 7 2006 11:00:00 GMT <![CDATA[ Manufacturer of Controlled Substances; Notice of Registration]]> http://thefederalregister.com/d.p/2006-12-07-E6-20697

By Notice dated July 25, 2006, and published in the Federal Register on July 31, 2006, (71 FR 4321143212), Roche Diagnostics Operations, Inc., Attn: Regulatory Compliance, 9115 Hague Road, Indianapolis, Indiana 46250, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in schedule I and II:
[[Page 70989]]
Drug Schedule Lysergic Acid Diethylamide (7315)............ I
Tetrahydrocannabinol (7370).................. I
Alphamethadol (9605)......................... I
Phencyclidine (7471)......................... II
Ecgonine (9180).............................. II
Methadone (9250)............................. II

Morphine (9300).............................. II

The company plans to manufacture small quantities of listed controlled substances for use in diagnostic products.

No comments or objections have been received. DEA has con ]]> http://thefederalregister.com/d.p/2006-12-07-E6-20697 Thu, Dec 7 2006 11:00:00 GMT <![CDATA[ Importer of Controlled Substances; Notice of Registration ]]> http://thefederalregister.com/d.p/2006-12-07-E6-20742

By Notice dated August 14, 2006 and published in the Federal Register on August 21, 2006, (71 FR 4855648557), Sigma Aldrich Manufacturing LLC., Subsidiary of Sigma Aldrich Manufacturing Company, 3500 Dekalb Street, St. Louis, Missouri 63118, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as an importer of the basic classes of controlled substances listed in schedule I and II:
Drug Schedule Cathinone (1235)........................... I
Methcathinone (1237)....................... I
Aminorex (1585)............................ I
Gamma Hydroxybutyric Acid (2010)........... I
Methaqualone (2565)........................ I
Ibogaine (7260)............................ I
Lysergic acid diethylamide (7315).......... I
Marihuana (7360)........................... I
Tetrahydrocannabinols (7370)............... I
Mescaline (7381)........................... I
4Bromo2,5dimethoxyamphetamine (7391).... I
4Bromo2,5dime ]]> http://thefederalregister.com/d.p/2006-12-07-E6-20742 Thu, Dec 7 2006 11:00:00 GMT <![CDATA[ Manufacturer of Controlled Substances; Notice of Registration]]> http://thefederalregister.com/d.p/2006-12-07-E6-20737

By Notice dated July 10, 2006, and published in the Federal Register on July 24, 2006, (71 FR 4183841839), Sigma Aldrich Research BioChemicals, Inc., 13 Strathmore Road, Natick, Massachusetts 01760, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in schedule I and II:
Drug Schedule Cathinone (1235).......................... I
Methcathinone (1237)...................... I
Aminorex (1585)........................... I
Alphaethyltryptamine (7249).............. I
Lysergic acid diethylamide (7315)......... I
Tetrahydrocannabinols (7370).............. I
[[Page 70990]]
4Bromo2,5dimethoxyampheta mine (7391). I
4Bromo2,5dimethoxyphenethylamine (7392) I
2,5Dimethoxyampheta mine (7396)......... I
3,4Methylenedioxyamphetamine (7400)...... I
NHydroxy3,4methylenedioxyamphetamine I
(7402).
3,4MethylenedioxyNethylamphetamine I
(740 ]]> http://thefederalregister.com/d.p/2006-12-07-E6-20737 Thu, Dec 7 2006 11:00:00 GMT <![CDATA[ Importer of Controlled Substances; Notice of Registration ]]> http://thefederalregister.com/d.p/2006-12-07-E6-20748

By Notice dated July 10, 2006, and published in the Federal Register on July 24, 2006, (71 FR 4183941840), Stepan Company, Natural Products Department, 100 W. Hunter Avenue, Maywood, New Jersey 07607, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as an importer of Coca Leaves (9040), a basic class of controlled substance listed in schedule II.

The company plans to import the listed controlled substance for the manufacture of bulk controlled substances and distribution to its customers.

No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and 952(a) and determined that the registration of Stepan Company to import this basic class of controlled substance is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971, at this time. DEA has investigated Stepan Company to ensure that the company's registration i ]]> http://thefederalregister.com/d.p/2006-12-07-E6-20748 Thu, Dec 7 2006 11:00:00 GMT <![CDATA[ Importer of Controlled Substances; Notice of Registration ]]> http://thefederalregister.com/d.p/2006-12-07-E6-20741

By Notice dated August 15, 2006 and published in the Federal Register on August 22, 2006, (71 FR 48948), Wildlife Laboratories, Inc., 1401 Duff Drive, Suite 400, Fort Collins, Colorado 80524, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as an importer of Etorphine Hydrochloride (9059), a basic class of controlled substance listed in schedule II.

The company plans to import the listed controlled substance for sale to its customers.

No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and 952(a) and determined that the registration of Wildlife Laboratories, Inc. to import the basic class of controlled substance is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971, at this time. DEA has investigated Wildlife Laboratories, Inc. to ensure that the company's registration is consistent with the public i ]]> http://thefederalregister.com/d.p/2006-12-07-E6-20741 Thu, Dec 7 2006 11:00:00 GMT